Репозиторий Университета

Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19


  • Avdeev S.N.
  • Yaroshetskiy A.I.
  • Tsareva N.A.
  • Merzhoeva Z.M.
  • Trushenko N.V.
  • Nekludova G.V.
  • Chikina S.Y.
Дата публикации:01.01.2021
Журнал: American Journal of Emergency Medicine
БД: Scopus
Ссылка: Scopus

Аннтотация

© 2020 Elsevier Inc. Aim: Noninvasive ventilation (NIV) is known to reduce intubation in patients with acute hypoxemic respiratory failure (AHRF). We aimed to assess the outcomes of NIV application in COVID-19 patients with AHRF. Materials & methods: In this retrospective cohort study, patients with confirmed diagnosis of COVID-19 and AHRF receiving NIV in general wards were recruited from two university-affiliated hospitals. Demographic, clinical, and laboratory data were recorded at admission. The failure of NIV was defined as intubation or death during the hospital stay. Results: Between April 8 and June 10, 2020, 61 patients were enrolled into the final cohort. NIV was successful in 44 out of 61 patients (72.1%), 17 patients who failed NIV therapy were intubated, and among them 15 died. Overall mortality rate was 24.6%. Patients who failed NIV were older, and had higher respiratory rate, PaCO2, D-dimer levels before NIV and higher minute ventilation and ventilatory ratio on the 1-st day of NIV. No healthcare workers were infected with SARS-CoV-2 during the study period. Conclusions: NIV is feasible in patients with COVID-19 and AHRF outside the intensive care unit, and it can be considered as a valuable option for the management of AHRF in these patients.


Вернуться назад